Discover Tenders by Antiretroviral Drugs Sector

Find the most relevant tenders for Antiretroviral Drugs. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Antiretroviral Drugs tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Antiretroviral Drugs tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Interferon Beta 1B Atc Code According To Who L03Ab08

Deadline: 31 May 2025

Germany

Ref. No.: 5040394

EMD:Ref Document

Bid Value: Ref Document

37 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Sultamicillin Atc Code According To Who J01Cr04

Deadline: 28 Feb 2026

Germany

Ref. No.: 5040083

EMD:Ref Document

Bid Value: Ref Document

310 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Octreotide Atc Code According To Who H01Cb02

Deadline: 31 May 2026

Germany

Ref. No.: 5038643

EMD:Ref Document

Bid Value: Ref Document

402 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Fampridine Atc Code According To Who N07Xx07

Deadline: 28 Feb 2026

Germany

Ref. No.: 5037763

EMD:Ref Document

Bid Value: Ref Document

310 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Milnacipran

Deadline: 10 Nov 2025

Germany

Ref. No.: 4951853

EMD:Ref Document

Bid Value: Ref Document

200 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Methyldopa

Deadline: 10 Nov 2025

Germany

Ref. No.: 4949920

EMD:Ref Document

Bid Value: Ref Document

200 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Sunitinib 37 5 Mg N1

Deadline: 10 Nov 2025

Germany

Ref. No.: 4945762

EMD:Ref Document

Bid Value: Ref Document

200 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Ibuprofen 800Mg Ret

Deadline: 10 Nov 2025

Germany

Ref. No.: 4945668

EMD:Ref Document

Bid Value: Ref Document

200 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Metoprolol Plus Hct 95 Mg 12 5 Mg

Deadline: 10 Nov 2025

Germany

Ref. No.: 4944109

EMD:Ref Document

Bid Value: Ref Document

200 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Sgb V With The Possibility Of Joining At Any Time So Called Approval Model 2024 04

Deadline: 05 Apr 2026

Germany

Ref. No.: 4943211

EMD:Ref Document

Bid Value: Ref Document

346 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Alitretinoin Atc Code D11Ah04

Deadline: 27 Mar 2026

Germany

Ref. No.: 4900610

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Leuprorelin Atc Code L02Ae02

Deadline: 27 Mar 2026

Germany

Ref. No.: 4899956

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Flupentixol Atc Code N05Af01

Deadline: 27 Mar 2026

Germany

Ref. No.: 4899215

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Eptinezumab N02Cd05 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4646012

EMD:Ref Document

Bid Value: Ref Document

310 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Pancreatin Lipase Containing Multienzymes A09Aa02 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4644671

EMD:Ref Document

Bid Value: Ref Document

310 Days Left

Showing 37891 to 37905 of 37981 results

‹
1
2
...
2524
2525
2526
2527
2528
2529
2530
2531
2532
2533
›

Discover Tenders by Antiretroviral Drugs Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Antiretroviral Drugs Sector

Filter Your Search

FREE Trial plan for all new users!